Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)

Clinical trial NCT01360645 · COMPLETED

Trial details

NCT number: NCT01360645
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder Depression Depressive Disorder, Major Mood Disorders Mental Disorders

Start date: 2011-07-01
Primary completion: 2013-05-01
Enrollment: 826

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.